Day One Biopharmaceuticals, Inc.
DAWNDelisted Apr 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Day One Biopharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 109 | 126 | +17 |
| Shares | 60.2M | 61.2M | +1.02M (+1.7%) |
| Value | $1.29B | $818.1M | −$470.9M (−36.5%) |
New holders (34)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (17)
Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Pathway Capital Management, LP | 995,686 | $21.4M |
| Deerfield Management Company, L.P. (Series C) | 964,033 | $20.7M |
| Point72 Asset Management, L.P. | 461,631 | $9.93M |
| Voloridge Investment Management, LLC | 146,041 | $3.14M |
| ExodusPoint Capital Management, LP | 65,929 | $1.42M |
| Group One Trading, L.P. | 45,586 | $981.0K |
| Cheyne Capital Management (UK) LLP | 27,223 | $585.8K |
| Penn Mutual Asset Management, LLC | 24,920 | $536.3K |
| Balyasny Asset Management LLC | 9,883 | $212.7K |
| ProShare Advisors LLC | 9,645 | $207.6K |
| Quantbot Technologies LP | 5,900 | $127.0K |
| Capital Analysts, LLC | 750 | $16.0K |
| Bellevue Asset Management, LLC | 62 | $1.31K |
| Accurate Wealth Management, LLC | 34 | $776 |
| Horan Securities, Inc. | 17 | $366 |
| Ellevest, Inc. | 13 | $280 |
| Credit Suisse AG | 1 | $22 |